CD79A and nasopharyngeal carcinoma: IgA reflects recent exposure along mucosal surfaces such as the oral epithelium and has proven to be an informative biomarker for EBV-associated epithelial tumors (e.g., nasopharyngeal carcinoma)12, 17.